From HuGE Literature Finder Database
This database contains published literature on genetic associations and other human genome epidemiology
- A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study.
Annals of oncology : official journal of the European Society for Medical Oncology 2017 May 28 (5): 996-1004.
Monk B J, Brady M F, Aghajanian C, Lankes H A, Rizack T, Leach J, Fowler J M, Higgins R, Hanjani P, Morgan M, Edwards R, Bradley W, Kolevska T, Foukas P, Swisher E M, Anderson K S, Gottardo R, Bryan J K, Newkirk M, Manjarrez K L, Mannel R S, Hershberg R M, Coukos - Analysis Suggests Wider Use for PARP Inhibitors.
Cancer discovery 2017 Apr .
Authors are not available - Higher antitumor activity of trabectedin in germline BRCA2 carriers with advanced breast cancer as compared to BRCA1 carriers: A subset analysis of a dedicated phase II trial.
Breast (Edinburgh, Scotland) 2017 Apr 34 18-23.
Ghouadni Amal, Delaloge Suzette, Lardelli Pilar, Kahatt Carmen, Byrski Tomasz, Blum Joanne L, Gonçalves Anthony, Campone Mario, Nieto Antonio, Alfaro Vicente, Cullell-Young Martin, Lubinski J - Impact of primary platinum-free interval and BRCA1/2 mutation status on treatment and survival in patients with recurrent ovarian cancer.
Gynecologic oncology 2017 Apr .
Bookman Michael A, Tyczynski Jerzy E, Espirito Janet L, Wilson Thomas W, Fernandes Ancilla - Analysis of chromosomal radiosensitivity of healthy BRCA2 mutation carriers and non-carriers in BRCA families with the G2 micronucleus assay.
Oncology reports 2017 Mar 37 (3): 1379-1386.
Baert Annelot, Depuydt Julie, Van Maerken Tom, Poppe Bruce, Malfait Fransiska, Van Damme Tim, De Nobele Sylvia, Perletti Gianpaolo, De Leeneer Kim, Claes Kathleen B M, Vral An
.png)
No hay comentarios:
Publicar un comentario